This blog post by Carelon Research highlights best practices in health disparities research following a three-step framework that emphasizes the pivotal role researchers play in detecting, understanding and reducing health disparities. Read it now: healtheconomics.com/best-practices…

UPCOMING WEBINAR 🖥️ ICON Plc | This discussion aims to provide an overview of systematic literature reviews as a tool, including what they are, how they are conducted, when to perform one & much more! You don't want to miss this one, secure your spot now: bit.ly/40beOBx

Join HealthEconomics.com’s Contributor Program and share your valuable insights and study snippets with a global audience. Contribute to our site and make a significant impact in the field of HEOR, RWE and Market Access. Submit your content here: healtheconomics.com/contributor-pr…

There's growing interest in conducting research that drives toward health equity among life sciences companies. In this article, Carelon Research shares best practices in health disparities research following a 3-step framework by Kilbourne et al (2006): healtheconomics.com/best-practices…

If you missed it, go watch it now!!! This webinar addresses so many great topics, watch below to hear the investor perspective on integrating market access considerations for biotechs... ... or watch the full webinar here: bit.ly/46azWJ4

In our recent blog post with ICON Plc, Immaculate Nevis MD, MBA, PhD and Liliane Martinez MD, MSc discuss how systematic literature reviews help inform more inclusive, diverse trial designs aligned with FDA DEI guidelines. Read the full article here: healtheconomics.com/enhancing-dive…

This episode of tHEORetically Speaking features experts from @TriNetX, who discuss the rise of RWD and its role in revolutionizing healthcare research, and how the TriNetX team approaches data quality to ensure research-ready RWD. Watch it now: bit.ly/3YqHaGM

At ISPOR Europe 2024, a key focus was the upcoming changes in HTA regulations. As the new JCA rules are set to take effect in Jan 2025, stakeholders across the healthcare sector are raising critical questions.    @Lumanity's article shares key insights: lumanity.com/perspectives/i…

Experts from ICON Plc present an overview of systematic literature reviews, detailing their purpose, execution, decision-making criteria & suitability for addressing key questions in the pharmaceutical industry. We hope to (virtually) see you there! bit.ly/40beOBx

There is growing interest in conducting research that drives toward health equity among life sciences companies. But how can progress be made? Check out our recent blog post to read how Carelon Research is contributing to advancing health equity: healtheconomics.com/best-practices…

In a groundbreaking collaboration, GSK has partnered with @Muna_Tx, a biotech startup, to advance Alzheimer’s drug research. Muna focuses on genetic code analysis to discover new treatment targets for neurodegenerative diseases. Read more here: healtheconomics.com/gsk-and-muna-t…

What role do systematic literature reviews play in informing more inclusive, diverse clinical trial designs aligned with FDA DEI guidelines? Find out in this blog post by Immaculate Nevis MD, MBA, PhD and Liliane Martinez MD, MSc from ICON Plc: healtheconomics.com/enhancing-dive…

We sat down for a conversation with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research & their unique value proposition for the life science industry. Read the interview now: healtheconomics.com/innovating-dif…

As the demand for value-based care grows, real-world evidence (#RWE) is becoming crucial in shaping healthcare decisions & optimizing patient outcomes. Learn how Carelon Research has successfully designed & executed impactful RWE-based value assessments: healtheconomics.com/facilitating-v…

In @Lumanity's latest thought leadership article, they explore the benefits and challenges of seeking earlier approval via the IRP and offer guidance on how to ensure successful NICE submissions. Check it out: lumanity.com/perspectives/t… #NICE #HTA #HEOR #LumanityPerspectives

The U.S. Government Accountability Office warns of higher premiums in 2025 due to market concentration, with 80% of enrollments dominated by just a few companies. Read more for insights on affordability and accessibility: healtheconomics.com/u-s-government…

In this on-demand webinar with @iconplc, experts present an overview of systematic literature reviews, detailing their purpose, execution, decision-making criteria & suitability for addressing key questions in the pharmaceutical industry. Watch it now: bit.ly/40beOBx

This blog post by Carelon Research highlights best practices in health disparities research following a three-step framework that emphasizes the pivotal role researchers play in detecting, understanding and reducing health disparities. Read it now: healtheconomics.com/best-practices…

The FDA is promoting broader representation in clinical trials in order to reduce bias, promote social justice, improve health equity & drive scientific innovation. Learn how systematic literature reviews can inform more diverse trial designs: healtheconomics.com/enhancing-dive… ICON Plc

Are you ready to extend and develop your skills and soar to new heights of knowledge in health economics? Look no further than The Centre for Health Economics Short Courses in Health Economics! bit.ly/cheshortcourses